Latest DNA Sequencing News

Advanced Biological Laboratories' DeepChek® and ViroScore® Suite Clinical Genotyping Solutions For Personalized Treatment of HIV Receive CE Mark for In Vitro Diagnostic UseAdvanced Biological Laboratories (ABL) announced today that DeepChek® and ViroScore® Suite clinical genotyping solutions are now CE-IVD (In Vitro Diagnostics) approved for commercial use in Europe and other countries that recognise CE certification. This approval is further validating the use of our next generation sequencing (NGS) downstream an...

Microorganism ID: Bacteria Identification Service by Altogen LabsAltogen Labs CRO, a preclinical contract research laboratory, announced its launch of microorganism ID bacteria identification service today. Microorganism identification and bioinformatic sequence characterization services are avail

Site-specific DICER and DROSHA RNA products control the DNA-damage responseNon-coding RNAs (ncRNAs) are involved in an increasingly recognized number of cellular events. Some ncRNAs are processed by DICER and DROSHA RNases to give rise to small double-stranded RNAs involved in RNA interference (RNAi). The DNA-damage respons...

High-throughput antibody sequencing reveals genetic evidence of global regulation of the naïve and memory repertoires that extends across individuals

U.K. providing $395.7M for bioscience researchThe U.K.'s Biotechnology and Biological Sciences Research Council awarded L250 million ($395.7 million) across eight institutes to fund bioscience research, including studies in healthcare, agriculture and energy. Institutes receiving funds for healt...

Human genetics: Not-so-rare gene variantsBy sequencing more human genomes more thoroughly than ever before, researchers have shown that most of the genetic variation in the human population is due to rare variants. These rare versions of genes are more likely to affect human health than are...

Whole genome sequencing of rare olfactory neuroblastomaThe Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing (WGS) of a rare nasal tract cancer called olfactory neuroblastoma (ONB).

Cold Spring Harbor Laboratory Joins the Illumina Genome NetworkIllumina, Inc. (NASDAQ:ILMN) today announced that the Cold Spring Harbor Laboratory (CSHL) has joined the Illumina Genome Network (IGN) to provide researchers with broader access to whole genome sequencing (WGS) services. IGN and CSHL will work in collaboration to bring together CSHL’s expertise in molecular biology and cancer genomics with Illumina’s...

Selexis SA and Fusion Antibodies Services Form Partnership to Speed Therapeutic Monoclonal Antibody DevelopmentCustomers will be able to seamlessly go from non-human MAbs to clinical candidate generated in a cGMP ready CHO cell line in 8 months. Clinical candidates are selected based on both expression and binding activity from stable CHO pools. Geneva, Switzerland (PRWEB) May 23, 2012 Selexis SA, a global life sciences company for drug discovery, cell line development and scale-up to manufacturing of th...

Sequencing Study Suggests How VRSA Evolves Independently in Each Patient

MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & SullivanLONDON, May 23, 2012 /PRNewswire/ -- A number of large pharmaceutical and biotech companies are keen to invest in life science research. Advances in genomic technologies and molecular biology segments will boost the microRNA (miRNA) research and tools market in the future. MicroRNA is set to unveil a new era in molecular diagnostics and in the development of effective therapeutics. New analy...

Science journal’s NEWSFOCUS section describes recent advances in sequencing technologyRapid DNA sequencing may soon become a routine part of each individual's medical record, providing enormous information previously sequestered in the human genome's 3 billion nucleotide bases. This week's NEWSFOCUS section of the journal Science desc...

[Articles] Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort studyOur results provide supportive evidence for the cognitive reserve hypothesis, showing that in middle-income countries as in high-income countries, education, literacy, verbal fluency, and motor sequencing confer substantial protection against the ons...

TGen-Scottsdale Healthcare conduct whole genome sequencing of rare olfactory neuroblastoma(The Translational Genomics Research Institute) The Translational Genomics Research Institute and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing of a rare nasal tract cancer called olfactory neurob...

Rapid DNA sequencing may soon be routine part of each patient's medical recordRapid DNA sequencing may soon become a routine part of each individual's medical record, providing enormous information previously sequestered in the human genome's 3 billion nucleotide bases. Recent advances in sequencing technology using a tiny ori...

NYGC to take delivery of Illumina systems, establish core sequencing operationsNYGC to take delivery of Illumina systems, establish core sequencing operations NEW YORK--(BUSINESS WIRE)--May 22, 2012-- New York Genome Center (NYGC) today announced the formal commencement of their collaborative relationship with Illumina, init...

New York Genome Center Announces Formal Commencement of Collaborative Relationship with IlluminaNew York Genome Center (NYGC) today announced the formal commencement of their collaborative relationship with Illumina, initiated in November 2011, when Illumina was selected as the Center’s lead sequencing technology provider. As a next step in this collaboration, the Center will begin taking delivery of Illumina HiSeq 2000 and 2500 sequencing systems,...

Sequence itand they will come!(Arizona State University) Rapid DNA sequencing may soon become a routine part of each individual's medical record, providing enormous information previously sequestered in the human genome's 3 billion nucleotide bases. This week's Newsfocus section...

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerLevi Garraway and colleagues report exome sequencing of 112 prostate adenocarcinomas and matched normal tissues. They identify novel recurrent mutations in several genes, including MED12, FOXA1 and SPOP. They find that tumors harboring SPOP mutations...

Extremely low-coverage sequencing and imputation increases power for genome-wide association studiesBogdan Pasaniuc, David Reich, Alkes Price and colleagues report analyses considering the potential of genome-wide association studies (GWAS) based on extremely low-coverage sequence data sets combined with imputation using data sets from the 1000 Gen...

Transgenomic Announces CE IVD Mark for the WAVE MCE System and SURVEYOR® Scan KRAS Kit in EuropeTransgenomic, Inc. (OTCBB: TBIO) today announced it has achieved CE IVD Mark registration in Europe for the diagnostic use of its proprietary WAVE MCE System and SURVEYOR® Scan KRAS Kit. Analysis of the KRAS gene is critical for treatment decision-making in many cancer types. Gaining the CE IVD Mark enables diagnostic product sales in countries in the Eur...

2b-RAD: a simple and flexible method for genome-wide genotypingGenotyping based on restriction site–associated (RAD) sequencing around type IIB enzyme recognition sites is reported. The streamlined reduced-representation approach features even and tunable genome coverage and enables large-scale genotyping stud...

Eureka Genomics Awarded Multi Year Contract to Assist Military Laboratory With DNA SequencingBased on collaborative work done for the past twelve months with the Armed Forces DNA Identification Laboratory (AFDIL), Eureka Genomics has been awarded a multi-year contract with AFDIL to provide forensic service support that should advance efforts to identify unknown remains from the Korean War. Standard Next Generation Sequencing technologies...

A delegation of the Consular Corps accredited in Barcelona shows interested for the Barcelona Science ParkDiplomatic representatives of 27 countries visited yesterday the PCB and the National Center for Genome Analysis, second in sequencing capacity in Europe.

Cambridge Healthtech Associates™ Announces Open Monoclonal Technology as Inaugural Signature Award™ WinnerSignature Award recognizes life sciences companies developing unique technologies NEEDHAM, Massachusetts (PRWEB) May 21, 2012 Cambridge Healthtech Associates™ (CHA™) today announced that Open Monoclonal Technology, Inc. (OMT) is the winner of its inaugural Signature Award™. The Signature Award honors organizations with promising biotechnologies, judged on the following criteria: 1) value p...

0 1 2 3 4 ›»

buy DNA Sequencing market research data and corporate reports now Advertisement